In the absence of data from RCTs, we present a review of the available observational data
In the absence of data from RCTs, we present a review of the available observational data. Authors’ conclusions The available randomized controlled literature does not permit any meaningful conclusions about the efficacy of any form of treatment for ocular myasthenia. read by both authors and the full texts of possibly relevant articles were reviewed. The references of all manuscripts included in the review were scanned to identify additional articles of WR 1065 relevance and experts in the field were contacted to identify additional WR 1065 published and unpublished data. Where necessary, we contacted authors for further information. Selection criteria Inclusion required meeting three criteria: (a) randomized (or quasi\randomized) controlled study design; (b) active treatment compared to placebo, no treatment or some other treatment; and (c) results reported separately for patients with ocular myasthenia (grade 1) as defined by the Myasthenia Gravis Foundation of America. Data collection and analysis We collected…